Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:18   Issue: 5
Pp: 401-401
M. Caraglia
DOI: 10.2174/156800961805180522071829



Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality free to download

Volume:18   Issue: 5
Pp: 402-404
Massimiliano Berretta and Raffaele Di Francia
DOI: 10.2174/156800961805180522072538



Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives

Volume:18   Issue: 5
Pp: 410-420
Lara Alessandrini, Tiziana Perin, Shahin Kadare, Lino del Pup, Lorenzo Memeo, Agostino Steffan, Lorenzo Colarossi, Massimiliano Berretta, Paolo De Paoli and Vincenzo Canzonieri*
DOI: 10.2174/1568009618666171129145703



Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives

Volume:18   Issue: 5
Pp: 421-429
Anna Nappi, Massimiliano Berretta, Carmela Romano, Salvatore Tafuto, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Chiara De Divitiis, Lara Alessandrini, Francesco Fiorica, Alessandro Ottaiano and Guglielmo Nasti*
DOI: 10.2174/1568009617666170209095143



The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration

Volume:18   Issue: 5
Pp: 430-441
Massimiliano Berretta*, Carmela Romano, Raffaele Di Francia, Chiara De Diviitis, Vincenzo Canzonieri, Michele Caraglia, Gaetano Facchini and Guglielmo Nasti
DOI: 10.2174/1568009617666170208162058



Melanoma Adjuvant Treatment: Current Insight and Clinical Features

Volume:18   Issue: 5
Pp: 442-456
Carmine D`Aniello, Francesco Perri, Giuseppina Della Vittoria Scarpati, Chiara Della Pepa, Salvatore Pisconti, Vincenzo Montesarchio, Nicolas Wernert, Mayra Rachele Zarone, Michele Caraglia, Gaetano Facchini*, Massimiliano Berretta and Carla Cavaliere
DOI: 10.2174/1568009617666170208163714



Optimal Management of Prostate Cancer Based on its Natural Clinical History

Volume:18   Issue: 5
Pp: 457-467
Gaetano Facchini*, Francesco Perri, Gabriella Misso, Carmine D`Aniello, Giuseppina Della Vittoria Scarpati, Sabrina Rossetti, Chiara Della Pepa, Salvatore Pisconti, Gerhard Unteregger, Alessia Cossu, Michele Caraglia, Massimiliano Berretta and Carla Cavaliere
DOI: 10.2174/1568009617666170209093101



Current and Emerging Treatments for Metastatic Renal Cell Carcinoma

Volume:18   Issue: 5
Pp: 468-479
Carla Cavaliere, Carmine D`Aniello, Chiara Della Pepa, Salvatore Pisconti, Massimiliano Berretta and Gaetano Facchini*
DOI: 10.2174/1568009617666170209094030



The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality

Volume:18   Issue: 5
Pp: 480-498
Sebastiano Bordonaro, Massimiliano Berretta, Antonino Carmelo Tralongo, Silvia Clementi, Brigida Stanzione and Paolo Tralongo*
DOI: 10.2174/1568009617666170209100322



Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy

Volume:18   Issue: 5
Pp: 499-511
Raffaele Di Francia*, Angela De Monaco, Mariangela Saggese, Giancarla Iaccarino, Stefania Crisci, Ferdinando Frigeri, Rosaria De Filippi, Massimiliano Berretta and Antonio Pinto
DOI: 10.2174/1568009617666170208162841